How much of Bunge's Q2 2026 earnings strength is operational versus accounting timing?

GAAP diluted EPS of $3.47 includes a $1.67 per share mark-to-market timing benefit, which Bunge excludes from adjusted EPS. Adjusted EPS of $2.00 is the better measure of underlying operating performance, and it still improved meaningfully from $1.31 a year ago. The mark-to-market effects are expected to reverse over time.

Why did Bunge raise its 2026 outlook, and which segments are driving it?

Bunge raised its full-year adjusted EPS range to $9.25-$9.75 from $9.00-$9.50. Soybean Processing and Refining is now expected to be higher and Softseed Processing and Refining slightly higher. Grain Merchandising and Milling is expected to be lower, while Tropical Oils and Corporate and Other are unchanged.

What is the status of the Viterra-related share buyback and how does it affect shareholders?

Bunge completed the $2 billion repurchase program tied to the Viterra transaction, buying about $250 million of shares in Q2. Weighted diluted shares increased to 195 million from 136 million year over year, reflecting the shares issued in the Viterra combination, so per-share comparisons should be read with this dilution in mind.

Are there concerns about Bunge's cash flow and balance sheet?

Operating cash flow was negative $1.126 billion in the first half, mainly because of inventory growth and working capital build, though adjusted FFO was $1.29 billion. Inventories rose to $15.5 billion, short-term debt to $4.6 billion, and long-term debt to $9.4 billion. Investors should watch whether readily marketable inventory and working capital unwind as expected.

What costs related to the Viterra integration are affecting results?

Acquisition and integration costs were $35 million pre-tax in Q2 ($32 million after tax) and are recorded mainly in Corporate and Other. Corporate and Other EBIT loss widened to $(166) million, and interest expense rose to $197 million from $106 million, reflecting the larger post-combination debt load. Management expects full-year net interest expense of $620-$660 million.

BG 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed July 29, 2026. Cited figures are marked; the original filing is the authoritative source.

Bunge Global SA (NYSE: BG) reported second quarter 2026 results on July 29, 2026, with GAAP diluted EPS of $3.47^a versus $2.61 a year earlier and adjusted diluted EPS of $2.00 versus $1.31.

The improvement was driven mainly by Soybean Processing and Refining and Softseed Processing and Refining, which benefited from a more favorable market environment and the expanded post-Viterra footprint. Net income attributable to Bunge rose to $678 million^b from $354 million, and total EBIT was $1,060 million versus $538 million. Note that the GAAP quarter was flattered by $437 million of mark-to-market timing gains, which management excludes from adjusted results, so the adjusted figures are the better guide to underlying performance.

Management raised its full-year 2026 adjusted EPS outlook to $9.25^c-$9.75 from $9.00-$9.50. Soybean Processing and Refining is now expected to be higher, Softseed slightly higher, and Grain Merchandising and Milling lower. Bunge also completed the roughly $2 billion share repurchase program tied to the Viterra transaction, buying back about $250 million of shares in the quarter.

Balance-sheet and cash-flow metrics show the scale of the combined company: inventories rose to $15.5 billion^d, of which $13.3 billion is readily marketable inventory, total debt increased, and operating cash flow was negative $1.1 billion for the first half, though adjusted funds from operations improved to $1.29 billion from $693 million. For investors, the key questions are how much of the earnings strength is durable versus timing-related, and whether the Viterra integration delivers the expected scale benefits.

Corporate costs, acquisition and integration expenses, higher interest expense ($197 million in the quarter versus $106 million), and rising working capital all warrant monitoring. The filing is furnished under Item 2.02 and is not deemed filed for Section 18 purposes.

02—Key points

Key Highlights

Q2 2026 adjusted diluted EPS of $2.00 vs. $1.31 a year ago; GAAP diluted EPS of $3.47 vs. $2.61, with GAAP inflated by $437M of mark-to-market timing gains
Total EBIT rose to $1,060M from $538M; adjusted Total EBIT rose to $665M from $293M
Soybean Processing and Refining segment EBIT of $804M vs. $460M, and Softseed Processing and Refining EBIT of $273M vs. $19M, driven by the expanded post-Viterra footprint and stronger processing margins
Full-year 2026 adjusted EPS outlook raised to $9.25-$9.75 from $9.00-$9.50
Completed the ~$2 billion share repurchase program tied to the Viterra transaction, with ~$250M repurchased in Q2; weighted diluted shares rose to 195M from 136M due to Viterra share issuance
Operating cash flow was negative $1,126M for the first half, though adjusted FFO improved to $1,291M from $693M; inventories rose to $15.5B, including $13.3B of RMI
Corporate and Other EBIT loss widened to $(166)M from $(118)M, mainly from Viterra-related overhead, and interest expense more than doubled to $197M in the quarter

03—Questions

Frequently Asked Questions

How much of Bunge's Q2 2026 earnings strength is operational versus accounting timing?
GAAP diluted EPS of $3.47 includes a $1.67 per share mark-to-market timing benefit, which Bunge excludes from adjusted EPS. Adjusted EPS of $2.00 is the better measure of underlying operating performance, and it still improved meaningfully from $1.31 a year ago. The mark-to-market effects are expected to reverse over time.
Why did Bunge raise its 2026 outlook, and which segments are driving it?
Bunge raised its full-year adjusted EPS range to $9.25-$9.75 from $9.00-$9.50. Soybean Processing and Refining is now expected to be higher and Softseed Processing and Refining slightly higher. Grain Merchandising and Milling is expected to be lower, while Tropical Oils and Corporate and Other are unchanged.
What is the status of the Viterra-related share buyback and how does it affect shareholders?
Bunge completed the $2 billion repurchase program tied to the Viterra transaction, buying about $250 million of shares in Q2. Weighted diluted shares increased to 195 million from 136 million year over year, reflecting the shares issued in the Viterra combination, so per-share comparisons should be read with this dilution in mind.
Are there concerns about Bunge's cash flow and balance sheet?
Operating cash flow was negative $1.126 billion in the first half, mainly because of inventory growth and working capital build, though adjusted FFO was $1.29 billion. Inventories rose to $15.5 billion, short-term debt to $4.6 billion, and long-term debt to $9.4 billion. Investors should watch whether readily marketable inventory and working capital unwind as expected.
What costs related to the Viterra integration are affecting results?
Acquisition and integration costs were $35 million pre-tax in Q2 ($32 million after tax) and are recorded mainly in Corporate and Other. Corporate and Other EBIT loss widened to $(166) million, and interest expense rose to $197 million from $106 million, reflecting the larger post-combination debt load. Management expects full-year net interest expense of $620-$660 million.

04—Continue

← View all 8-K filings